Clinics, Financial Model, Health Care, Service Businesses

5-year Financial Projections, Break-Even, Business Plans, Business Valuation, Cash Flow Projections, Dashboard, Debt Amortization, Debt Schedule, Debt Service Coverage, Excel, Financial Feasibility, Financial Model, Financial Modeling, Financial Planning, Financial Projections, Financing, Forecasting, KPIs (Key Performance Indicators), Loans, Mergers and Acquisitions Model, Payback Period, Pro-Forma, Profitability Analysis, Revenue Projections, Scenario Analysis, Sensitivity Analysis, Uses and Sources of Funds

Buy a veterinary practice and underwrite it the way an SBA lender actually will — not the way the broker’s add-back sheet wants you to. This is a lender-ready acquisition model for a single companion-animal practice, built around the two things that decide a vet deal: how much the doctors produce, and what it costs to replace the seller’s own chair once you own it.

The engine most templates skip. Revenue is built bottom-up from the doctors — FTE veterinarians times revenue per DVM — plus the recurring wellness-plan book (enrolled pets times annual fee) and pharmacy/retail, each carried at its own gross margin, so Gross Profit and SDE fall out of the mix, not a guessed number.

The owner-veterinarian production replacement. The owner is usually a producing doctor; if the buyer does not hold a DVM licence, they must re-hire that chair with an associate at a production (ProSal ~22%) wage, on top of a practice-manager salary. The model deducts both to reach Adjusted EBITDA and shows the TRUE DSCR (1.34x) next to the NAIVE broker-style DSCR (1.80x) — the gap is the seller’s own production, and it is exactly what separates a financeable vet deal from one that looks great on paper and gets declined.

What is inside: a Veterinary Revenue Engine (provider productivity + wellness recurring book + pharmacy, with a support-staff capacity check); SDE & Valuation with the owner-vet add-back; a 3-part SBA 7(a) capital stack with a full-standby vs amortizing seller-note toggle; a DSCR & Debt gate with debt yield, the wellness-book coverage (~123%) and a doctor-shortage down-case DSCR (0.73x); a 5-year P&L, Returns & Exit, a Dashboard, and a Benchmarks & Sources tab. Three practice profiles.

Honest by design. SDE margin held at a realistic ~21%; independents priced at ~3x SDE (~4-6x EBITDA) — the corporate consolidator’s 11-15x is NOT sold as your return; no IRR is headlined. 10 sheets, machine-verified across three engines, Excel and Google Sheets, no macros. Educational planning tool, not financial, legal or investment advice.

You must log in to submit a review.